AnanthJ. W., BanT. A., LehmannH. E., and BennettJ.: Nicotinic acid in the prevention and treatment of methionine induced exacerbation of psychopathology in schizophrenics.Canad. Psychiat. Ass. J.15: 15–20, 1970.
2.
BanT. A., and LehmannH. E.: Nicotinic acid in the treatment of schizophrenics.Canad. Psychiat. Ass. J.15: 499–500, 1970.
3.
CottA. A.: Treatment of ambulant schizophrenics with vitamin B-3 and relative hypoglycemic diet.J. Schizophrenia1: 189–196, 1967.
4.
CottA. A.: Treatment of schizophrenic children.Schizophrenia1: 44–59, 1969.
5.
CottA. A.: The parenteral use of vitamins in the treatment of schizophrenia.Schizophrenia2: 177–179, 1970.
6.
FoyJ. G.: Gone is Shadow's Child.Watchung, New Jersey: Watchung Book Sales, 1970.
7.
GreenR. G.: Reading disability.Canad. Med. Ass. J.100: 586, 1969.
8.
GreenR. G.: Protein poor diet means pellagra.Canad. Family Physician16: 88, 1970.
9.
GreenR. G.: Subclinical pellagra: Its diagnosis and treatment.Schizophrenia2: 70–79, 1970.
10.
GreenbaumG. H. C.: An evaluation of niacinamide in the treatment of childhood schizophrenia.Amer. J. Psychiat.127: 129–132, 1970.
11.
HofferA.: Niacin Therapy in Psychiatry.Springfield, Illinois: Charles C. Thomas, 1962.
12.
HofferA.: Nicotinic acid: An adjunct in the treatment of schizophrenia.Amer. J. Psychiat.120: 171–173, 1963.
13.
HofferA.: Treatment of organic psychosis with nicotinic acid.Dis. Nerv. Syst.26: 358–360, 1965.
14.
HofferA.: The effect of nicotinic acid on the frequency and duration of re-hospitalization of schizophrenic patients: A controlled comparison study.Int. J. Neuropsychiat.2: 236–240, 1966.
15.
HofferA.: Malvaria and the law.Psychosomatics7: 303–310, 1966.
16.
HofferA.: Enzymology of Hallucinogens.Philadelphia: J. B. Lippincott, 1966.
17.
HofferA.: The effect of nicotinic acid on the frequency and duration of re-hospitalization of schizophrenic patients: A controlled comparison study.Int. J. Neuro-Psychiat.2: 234–240, 1966.
18.
HofferA.: Use of nicotinic acid and/or nicotinamide in high doses to treat schizophrenia.Canad. I. Psychiat. Nursing7: 5–6, 1966.
19.
HofferA.: Biochemistry of nicotinic acid and nicotinamide.Psychosomatics8: 95–100, 1967.
20.
HofferA.: Treatment of schizophrenia with therapeutic program based upon nicotinic acid as the main variable.Molecular Basis of Some Aspects of Mental Activity.2: New York, Academic Press, pp. 435–456, 1967.
21.
HofferA.: A program for treating schizophrenia and other conditions using mega-vitamin therapy.Saskatoon: Modern Press, 1967, Available from A. Hoffer.
22.
HofferA.: Five California schizophrenics.J. Schizophrenia1: 209–220, 1967.
23.
HofferA.: Comparison of xanthine nicotinate and nicotinic acid as treatment for schizophrenia.Schizophrenia1: 24–37, 1969.
24.
HofferA.: Adverse effects of niacin in emergent psychosis.J. Amer. Med. Ass.207: 1355, 1969.
HofferA.: Safety, side effects and relative lack of toxicity of nicotinic acid and nicotinamide.Schizophrenia1: 78–87, 1969.
27.
HofferA.: Pellagra and schizophrenia.Psychosomatics11: 522–525, 1970.
28.
HofferA.: Childhood schizophrenia: A case treated with nicotinic acid and nicotinamide.Schizophrenia2: 43–53, 1970.
29.
HofferA., and O'ReganJ. B.: Letter: on “Unilateral ECT”.Biol. Psychiat.3: 95–96, 1971.
30.
HofferA., and OsmondH.: A card sorting test helpful in making psychiatric diagnosis.J. Neuropsychiat.2: 306–330, 1961.
31.
HofferA., and OsmondH.: Double blind clinical trials.J. Neuropsychiat.2: 221–227, 1961.
32.
HofferA., and OsmondH.: The presence of unidentified substances in the urine of psychiatric patients.J. Neuropsychiat.2: 331–362, 1961.
33.
HofferA., and OsmondH.: The Chemical Basis of Clinical Psychiatry.Springfield, Illinois: Charles C. Thomas, 1960.
34.
HofferA., and OsmondH.: Some schizophrenic recoveries.Dis. Nerv. Syst.23: 204–210, 1962.
35.
HofferA., and OsmondH.: Malvaria: A new psychiatric disease.Acta Psychiat. Scand.39: 335–366, 1963.
36.
HofferA., and OsmondH.: Some problems of stochastic psychiatry.J. Neuropsychiat.5: 97–11, 1963.
37.
HofferA., and OsmondH.: Treatment of schizophrenia with nicotinic acid.Acta Psychiat. Scand.40: 171–189, 1964.
38.
HofferA., and OsmondH.: How to Live with Schizophrenia.New Hyde Park, New York: University Books,1966.
39.
HofferA., and OsmondH.: The Hallucinogens.New York: Academic Press, 1967.
40.
HofferA. and OsmondH., CallbeckM. J., and KahanI.: Treatment of schizophrenia with nicotinic acid and nicotinamide.J. Clin. Exper. Psychopath.18: 131–158, 1957.
41.
IrvineD., BayneW., and MiyashitaH.: Identification of kryptopyrrole in human urine and its relation to psychosis.Nature224: 811–813, 1969.
42.
KeimH., HofferA., and OsmondH.: Hoffer-Osmond Diagnostic Test Manual.Saskatoon, Saskatchewan: Modern Press, 1967.
43.
NewboldH. L.: How one psychiatrist began using niacin.Schizophrenia2: 150–160, 1970.
44.
O'ReillyP. O.: Nicotinic acid therapy and the chronic schizophrenic.Dis. Nerv. Syst.16: 67–72, 1955.
45.
OsmondH.: Background to the niacin treatment.J. Schizophrenia1: 125–132, 1967.
46.
OsmondH., and HofferA.: Massive niacin treatment in schizophrenia. Review of a nine-year study.Lancet1: 316–320, 1962.
47.
OsmondH., and HofferA.: Schizophrenia and suicide.J. Schizophrenia1: 54–64, 1967.
48.
RamsayR. A., BanT. A., LehmannH. E., SaxenaM. A., and BennettJ.: Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients.Canad. Med. Ass. J.102: 939–942, 1970.
49.
RappM. S.: Use and abuse of drugs.Canad. Med. Ass. J.98: 922, 1968.
50.
RimlandB.: High dosage levels of certain vitamins in the treatment of children with severe mental disorders. In Ortho-molecular Psychiatry. Editors: Linus Pauling and David R. Hawkins. San Francisco: Freeman Press. In press.